Simvastatin and uterine fibroids: opportunity for a novel therapeutic option

Reflections
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Simvastatin and uterine fibroids: opportunity for a novel therapeutic option
Like

Volume 110, Issue 7, Pages 1272–1273

Authors:

Mohamed Ali, B. Pharm., M.Sc., Tia Jackson-Bey, M.D., M.P.H., Ayman Al-Hendy, M.D., Ph.D.

Abstract:

Reflections on "Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production" by Malik et al.


Read the full text here.

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Please sign in or register for FREE

Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.

Sign In Register

Recommended Content